Viatris unit Mylan, former President Rajiv Malik cleared in US Department of Justice generic drug antitrust probe Ruchika Sharma4 July 2024 1:00 PM ISTPittsburgh: Viatris Inc. has announced that the Antitrust Division of the U.S. Department of Justice (DOJ) has advised that it no longer...
Health Bulletin 23/October/2023 Roshni Dhar23 Oct 2023 5:41 PM ISTHere are the top health stories for the day:Procuring Rs 650 Remdesivir at Rs 1568 during pandemic: FIR against pharma company Mylan for alleged Rs 6...
Procuring Rs 650 Remdesivir at Rs 1568 during pandemic: FIR against pharma company Mylan for alleged Rs 6 crore fraud Farhat Nasim23 Oct 2023 12:54 PM ISTMumbai: Brewing controversy, the Mumbai Police's Economic Offences Wing (EOW) has filed an FIR against drug major Mylan Laboratories for alleged...
Rajiv Malik to retire as President of Viatris effective April 1, 2024 Ruchika Sharma23 Oct 2023 11:15 AM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced that its President, Rajiv Malik, will be retiring as an executive of the...
Viatris to divest India API, women's healthcare businesses for USD 1.2 billion Roshni Dhar5 Oct 2023 3:52 PM ISTViatris (formerly known as Mylan Inc) has finalised two deals in India to divest its API (active pharmaceutical ingredients) and women's healthcare...
US pharma giant Viatris to divest India API, women's healthcare businesses for USD 1.2 billion Ruchika Sharma3 Oct 2023 5:30 PM ISTBoth the India deals are expected to close in Q1 2024, according to the Viatris statement.
Trademark Infringement Suit: Delhi HC awards Rs 5 lakh cost to Sun Pharma over Oxiplat mark Farhat Nasim9 Aug 2023 6:51 PM ISTNew Delhi: Ruling in favour of Sun Pharmaceuticals Ltd. (Sun Pharma), Delhi High Court has awarded costs of Rs 5 lakh to the drug giant in a trademark...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
Biocon partner Viatris gets Complete Response Letter from USFDA for Bevacizumab license application Ruchika Sharma13 Feb 2023 11:13 AM ISTBevacizumab is a medication used to treat a number of types of cancers and a specific eye disease.
Mylan Gets CDSCO Panel Nod To Study COPD drug Revefenacin inhalation solution Dr. Divya Colin18 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug...
Mylan, Apple lose US Supreme Court bids to challenge patent review rule Roshni Dhar24 Jan 2022 6:02 PM ISTThe U.S. Supreme Court on Tuesday turned back challenges by Apple Inc and drugmaker Mylan Laboratories Ltd to a rule change that made it harder to...
Health Bulletin 24/January/2022 Roshni Dhar24 Jan 2022 5:35 PM ISTHere are Top Health stories of the dayDelhi: Cases dip, govt to bring up easing restrictions with L-GPay annual DNB course fee directly to NBE:...
